Cardio Diagnostics Correlations

CDIOW Stock  USD 0.04  0  9.24%   
The current 90-days correlation between Cardio Diagnostics and Eliem Therapeutics is -0.04 (i.e., Good diversification). The correlation of Cardio Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Cardio Diagnostics Correlation With Market

Average diversification

The correlation between Cardio Diagnostics Holdings and DJI is 0.14 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardio Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
SCPHELYM
MCRBELYM
MCRBSCPH
LUMOMIST
  
High negative correlations   
LUMOELYM
LUMOMCRB
LUMOSCPH
MISTELYM
MISTSCPH
MCRBMIST

Risk-Adjusted Indicators

There is a big difference between Cardio Stock performing well and Cardio Diagnostics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cardio Diagnostics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Cardio Diagnostics Corporate Management

Esq JDChief OfficerProfile
Timur DoganChief OfficerProfile
Khullani JDVice StrategyProfile
MBA JDCFO DirectorProfile
Khullani AbdullahVP StrategyProfile